Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Rectal Neoplasms 8Squamous Cell Carcinoma of Head and Neck 6Esophageal Neoplasms 6Oropharyngeal Neoplasms 5Uterine Cervical Neoplasms 4Head and Neck Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Hypopharyngeal Neoplasms 3Radiation Injuries 2Nasopharyngeal Carcinoma 2Lung Neoplasms 2Laryngeal Neoplasms 2Glioblastoma 2Esophageal Squamous Cell Carcinoma 2Vaginal Neoplasms 1Uterine Cervical Dysplasia 1Sinonasal Squamous Cell Carcinoma 1Rectal Malignant Neoplasms 1Postoperative Complications 1Pathologic Complete Response 1Papillomavirus Infections 1Pancreatic Neoplasms 1Ototoxicity 1Neoplasms 1Myelosuppression 1Mouth Neoplasms 1Margins of Excision 1Malignant Tumor of Lacrimal Drainage Structure 1Low Anterior Resection Syndrome 1Locally Advanced Hypopharyngeal Carcinoma 1

Interventions

Injections 16pembrolizumab 6Bevacizumab 6Paclitaxel 4Leucovorin 4Fluorouracil 4Carboplatin 4fludarabine 3Pemetrexed 3Oxaliplatin 3Capecitabine 3toripalimab 2sotorasib 2Immune Checkpoint Inhibitors 2Fulvestrant 2Drug Therapy 2Docetaxel 2Cyclophosphamide 2Cisplatin 2130-nm albumin-bound paclitaxel 2zimberelimab 1trifluridine tipiracil drug combination 1trametinib 1tislelizumab 1sacituzumab govitecan 1palbociclib 1osimertinib 1olaparib 1lazertinib 1fluzoparib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Advanced Solid Tumors × Chemoradiotherapy × Clear all
NCT06719362 2025-07-10

A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies

Providence Health & Services

Phase 1 Recruiting
110 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡